Global Health Group, University of California San Francisco, San Francisco, California, United States of America.
PLoS One. 2013 Apr 23;8(4):e60669. doi: 10.1371/journal.pone.0060669. Print 2013.
The private sector plays a large role in health services delivery in low- and middle-income countries; yet significant gaps remain in the quality and accessibility of private sector services. Clinical social franchising, which applies the commercial franchising model to achieve social goals and improve health care, is increasingly used in developing countries to respond to these limitations. Despite the growth of this approach, limited evidence documents the effect of social franchising on improving health care quality and access.
We examined peer-reviewed and grey literature to evaluate the effect of social franchising on health care quality, equity, cost-effectiveness, and health outcomes. We included all studies of clinical social franchise programs located in low- and middle-income countries. We assessed study bias using the WHO-Johns Hopkins Rigour Scale and used narrative synthesis to evaluate the findings.
Of 113 identified articles, 23 were included in this review; these evaluated a small sample of franchises globally and focused on reproductive health franchises. Results varied widely across outcomes and programs. Social franchising was positively associated with increased client volume and client satisfaction. The findings on health care utilization and health impact were mixed; some studies find that franchises significantly outperform other models of health care, while others show franchises are equivalent to or worse than other private or public clinics. In two areas, cost-effectiveness and equity, social franchises were generally found to have poorer outcomes.
Our review indicates that social franchising may strengthen some elements of private sector health care. However, gaps in the evidence remain. Additional research should include: further documentation of the effect of social franchising, evaluating the equity and cost-effectiveness of this intervention, and assessing the role of franchising within the context of the greater healthcare delivery system.
私营部门在中低收入国家的医疗服务提供中发挥着重要作用;然而,私营部门服务的质量和可及性仍存在很大差距。临床社会特许经营是将商业特许经营模式应用于实现社会目标和改善医疗保健的一种方式,它在发展中国家越来越多地被用来应对这些限制。尽管这种方法得到了发展,但有限的证据表明社会特许经营对改善医疗保健质量和可及性的影响。
我们查阅了同行评议和灰色文献,以评估社会特许经营对医疗质量、公平性、成本效益和健康结果的影响。我们纳入了所有位于中低收入国家的临床社会特许经营项目的研究。我们使用世界卫生组织-约翰霍普金斯严谨度量表评估研究偏倚,并使用叙述性综合评估研究结果。
在 113 篇已确定的文章中,有 23 篇被纳入本综述;这些研究评估了全球一小部分特许经营,并集中在生殖健康特许经营上。结果因结果和项目而异。社会特许经营与客户数量增加和客户满意度提高呈正相关。关于医疗利用和健康影响的结果不一;一些研究发现,特许经营显著优于其他医疗模式,而其他研究则表明特许经营与其他私人或公共诊所相当或更差。在成本效益和公平性两个方面,社会特许经营的结果通常较差。
我们的综述表明,社会特许经营可能会加强私营部门医疗的某些方面。然而,证据仍存在差距。进一步的研究应包括:进一步记录社会特许经营的效果,评估这种干预措施的公平性和成本效益,以及评估特许经营在更广泛的医疗服务提供系统中的作用。